In a landmark moment for cardiovascular medicine, Dr. Rebecca T. Hahn has been announced as the recipient of the prestigious TCT® Geoffrey O. Hartzler Master Operator Award, a distinction traditionally reserved for pioneering physicians in interventional cardiology. This accolade will be officially conferred during the Transcatheter Cardiovascular Therapeutics® (TCT®) annual scientific symposium, scheduled to convene from October 31 to November 3, 2026, in San Diego, California. What makes Dr. Hahn’s recognition groundbreaking is that she is the very first imaging specialist to be honored with this award, underscoring the transformative impact she has had in entwining advanced cardiovascular imaging with interventional procedures.
Dr. Hahn’s career is a testament to the critical evolution of cardiac imaging as an indispensable pillar in structural heart disease management. Her work has revolutionized interventional echocardiography, a field she not only founded but has continually expanded, enabling clinicians worldwide to perform precise diagnoses and deliver tailored treatments for structural heart abnormalities. Through her efforts, imaging has transcended its traditional role as a mere supportive tool, becoming a dynamic, procedure-guiding discipline essential for the successful execution of transcatheter and minimally invasive cardiac therapies.
Her influence extends beyond clinical innovation into academia and mentorship, where she has cultivated a new generation of imaging experts. These specialists are equipped to collaborate effectively within heart teams, combining their interpretive acumen with interventional skill sets. Dr. Hahn’s dedication to education is evident in her global footprint; she frequently visits catheterization laboratories internationally to disseminate her novel imaging protocols and elevate care standards. This hands-on training approach ensures consistency and optimizes patient outcomes across diverse healthcare environments.
Renowned cardiologist Dr. Martin B. Leon, Founder and Chairman Emeritus of the Cardiovascular Research Foundation (CRF), extolled Dr. Hahn’s contributions, describing her as “the embodiment of excellence.” He highlighted her “unmatched clinical acumen, academic leadership, and communication prowess,” noting her creation of an entirely new field that has spurred fresh educational methodologies and invigorated the interventional cardiology community. Dr. Leon emphasized that her success exemplifies the “heart team” strategy, where imaging specialists and operators operate in seamless synergy to advance procedural safety and effectiveness.
Dr. Hahn herself expressed profound humility and honor at receiving this award, recognizing it not just as personal recognition but as emblematic of the strides made in validating imaging’s pivotal role in interventional cardiology. She credited the exceptional teams she has collaborated with over her career for their integral support in pushing the boundaries of imaging-guided interventions. This acknowledgment signals a broader shift within cardiovascular medicine toward embracing interdisciplinary collaboration that bridges anatomy imaging, device technology, and surgical expertise.
Currently, Dr. Hahn holds key leadership roles that further cement her status as a luminary in the field. She serves as Chief Scientific Officer of the Echocardiography Core Laboratory at the CRF Clinical Trials Center, where she oversees imaging analyses that underpin clinical studies validating new therapies. At the Columbia Structural Heart & Valve Center, she is the Director of Interventional Echocardiography, guiding imaging strategies that optimize transcatheter valve procedures. Additionally, she holds a professorship in medicine at the Columbia University College of Physicians and Surgeons, shaping medical curricula that integrate imaging innovations into clinical practice.
Since joining Columbia | Interventional Cardiovascular Care in 2009, Dr. Hahn has spearheaded the creation of their Interventional Echocardiography program and the first dedicated fellowship in this emerging specialty. This initiative has cultivated expertise focused on imaging modalities that inform device deployment and procedural navigation in the cath lab. Her influence extends to professional societies, where she has directed the Annual State-of-the-Art Echo Course, educating hundreds on evolving guidelines from the American Society of Echocardiography (ASE), ensuring that cutting-edge recommendations reach frontline caregivers.
Her prolific academic output is remarkable, with over 565 peer-reviewed journal articles and 11 book chapters exploring echocardiographic techniques and valvular heart disease. Dr. Hahn has played instrumental roles on multiple writing committees for ASE recommendations and guidelines from the Academic Research Consortium, contributing critical expert insight that shapes nationwide standards in cardiac imaging. Beyond academia, she has led landmark clinical trials such as the SCOUT Trial for the Trialign annuloplasty device and co-led the pivotal Triscend II trial, which led to FDA approval of the EVOQUE Transcatheter Tricuspid Valve Replacement device, demonstrating her dual expertise in research and clinical innovation.
Her global renown is reflected by numerous invited lectures and grand rounds presentations at prestigious institutions worldwide, enhancing dialogue on structural heart disease management and imaging integration. This international recognition complements a distinguished array of awards, including a 2023 Physician Lifetime Achievement Award from ASE and a 2025 Lifetime Achievement Award from CSI, alongside delivering the esteemed Rene Laennec Lecture at the European Society of Cardiology meeting in 2025—demonstrating enduring leadership across continents.
Dr. Hahn’s pathways into cardiology were forged at New York Hospital/Cornell Medical Center, where she completed her residency, internship, and cardiology fellowship, including administrative leadership as assistant chief resident. She earned her medical degree from Washington University in St. Louis, Missouri, and holds esteemed fellowships from leading professional organizations, including the ASE, American College of Cardiology, and European Society of Cardiology, validating her stature as an international expert in cardiovascular imaging.
The TCT Geoffrey O. Hartzler Master Operator Award, named after one of the field’s most respected pioneers, has historically honored interventionalists whose technical mastery and leadership have advanced cardiovascular care. Past recipients represent a distinguished roster of cardiologists such as Eberhard Grube, Osamu Katoh, and Jeffrey W. Moses, who have shaped global practices in transcatheter therapies. Dr. Hahn’s inclusion in this elite group signals a paradigm shift recognizing imaging innovation as equally vital to procedural success and patient outcomes, heralding a new era for heart teams worldwide.
The Cardiovascular Research Foundation (CRF) and TCT symposium remain at the forefront of interventional cardiovascular medicine, fostering the translation of technological breakthroughs into clinical practice. Their mission emphasizes innovation, scientific rigor, and education, underpinning advances that enhance survival and quality of life for millions affected by cardiovascular diseases globally. TCT 2026 promises to continue this legacy by spotlighting transformative discoveries, such as Dr. Hahn’s work, that redefine how clinicians diagnose, intervene, and collaborate in structural heart disease treatment.
As the medical community celebrates Dr. Rebecca T. Hahn’s recognition with the TCT Geoffrey O. Hartzler Master Operator Award, her pioneering efforts illuminate the indispensable role of imaging specialists in the heart team. Her career thus far has reshaped the landscape of interventional cardiology, merging imaging excellence with procedural innovation to chart a pathway toward safer, more effective, and individualized patient care in structural heart disease.
Subject of Research:
Advancements and leadership in interventional echocardiography and imaging-guided cardiovascular interventions.
Article Title:
Dr. Rebecca T. Hahn: Pioneering Imaging Excellence Honored with TCT Geoffrey O. Hartzler Master Operator Award
News Publication Date:
May 7, 2026
Web References:
www.crf.org
www.tctconference.com
Keywords:
Interventional Echocardiography, Structural Heart Disease, Cardiovascular Imaging, Transcatheter Valve Replacement, TCT Geoffrey O. Hartzler Master Operator Award, Cardiovascular Research Foundation, Heart Team, Echocardiography, Clinical Cardiology, Medical Innovation, Cardiology Fellowship, Echocardiography Guidelines
Tags: cardiac imaging in interventional procedurescardiovascular imaging innovationsevolution of cardiac imaging techniquesgroundbreaking female cardiologistsinterventional cardiology pioneersinterventional echocardiography advancementsmentorship in cardiologyminimally invasive cardiac therapiesRebecca T. Hahn MD award recipientstructural heart disease managementTCT 2026 Master Operator Awardtranscatheter cardiovascular therapeutics 2026
